Müssig Karsten, Leyhe Thomas, Besemer Britta, Saur Ralf, Häring Hans-Ulrich, Gallwitz Baptist, Klingberg Stefan
Division of Endocrinology, Diabetes, Angiology, Nephrology, and Clinical Chemistry, Department of Internal Medicine, University Hospital of Tübingen, Tübingen, Germany.
J Int Neuropsychol Soc. 2009 Sep;15(5):803-6. doi: 10.1017/S1355617709990324. Epub 2009 Jul 29.
Pituitary adenomas, even after successful treatment, are associated with cognitive dysfunctions. We hypothesized that an association between the age of the patients at pituitary surgery and neuropsychological outcome may exist. Forty-two patients (mean age 51 +/- 10 years) who had been successfully treated for pituitary adenoma (surgery with or without subsequent radiotherapy) underwent neuropsychological testing. Age at treatment (mean 37 +/- 11 years) was significantly associated with Trail Making Test, Part B (TMT-B) results, a measure of executive control and attention (r = .60, p < .0001). This association remained significant after adjustment for age at testing and time since treatment (r = .42, p = .008). No associations were detected between age at treatment and Trail Making Test, Part A (TMT-A, attentional speed), the digit span test (acoustic working memory), and the German version of the Auditory Verbal Learning and Memory, and Memory Test (verbal memory, all p > or = .3). Our data suggest a favorable effect of younger age at treatment in adults on neurocognitive outcome after surgery for pituitary adenoma.
垂体腺瘤即使在成功治疗后也与认知功能障碍有关。我们推测垂体手术时患者的年龄与神经心理学结果之间可能存在关联。42例(平均年龄51±10岁)成功治疗垂体腺瘤(手术加或不加后续放疗)的患者接受了神经心理学测试。治疗时的年龄(平均37±11岁)与用于衡量执行控制和注意力的连线测验B(TMT-B)结果显著相关(r = 0.60,p < 0.0001)。在校正测试时的年龄和治疗后的时间后,这种关联仍然显著(r = 0.42,p = 0.008)。在治疗时的年龄与连线测验A(TMT-A,注意力速度)、数字广度测验(听觉工作记忆)以及德语版听觉言语学习与记忆和记忆测验(言语记忆,所有p≥0.3)之间未检测到关联。我们的数据表明,成人治疗时年龄较小对垂体腺瘤手术后的神经认知结果有有利影响。